HomeKURA • NASDAQ
add
Kura Oncology Inc
Previous close
$11.95
Day range
$11.67 - $12.31
Year range
$5.41 - $12.49
Market cap
1.02B USD
Avg Volume
2.08M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 20.75M | — |
Operating expense | 97.54M | 73.20% |
Net income | -74.12M | -36.23% |
Net profit margin | -357.19 | — |
Earnings per share | -0.85 | -34.92% |
EBITDA | -79.83M | -33.78% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 549.66M | 20.73% |
Total assets | 649.38M | 35.62% |
Total liabilities | 406.84M | 638.82% |
Total equity | 242.54M | — |
Shares outstanding | 87.02M | — |
Price to book | 4.28 | — |
Return on assets | -30.03% | — |
Return on capital | -68.14% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -74.12M | -36.23% |
Cash from operations | -80.63M | -85.61% |
Cash from investing | 93.97M | 106.36% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | 13.34M | 210.43% |
Free cash flow | -70.16M | -205.49% |
About
Founded
2014
Headquarters
Website
Employees
192